Publications by authors named "F Eisenhaber"

Four genes-DAND5, PKD1L1, MMP21, and CIROP-form a genetic module that has specifically evolved in vertebrate species that harbor motile cilia in their left-right organizer (LRO). We find here that CIROZ (previously known as C1orf127) is also specifically expressed in the LRO of mice, frogs, and fish, where it encodes a protein with a signal peptide followed by 3 zona pellucida N domains, consistent with extracellular localization. We report 16 individuals from 10 families with bi-allelic CIROZ inactivation variants, which cause heterotaxy with congenital heart defects.

View Article and Find Full Text PDF

Uncovering the regulators of cellular aging will unravel the complexity of aging biology and identify potential therapeutic interventions to delay the onset and progress of chronic, aging-related diseases. In this work, we systematically compared genesets involved in regulating the lifespan of (a powerful model organism to study the cellular aging of humans) and those with expression changes under rapamycin treatment. Among the functionally uncharacterized genes in the overlap set, stood out as the only one downregulated by rapamycin and with an increased chronological and replicative lifespan upon deletion.

View Article and Find Full Text PDF

CD24 is frequently overexpressed in ovarian cancer and promotes immune evasion by interacting with its receptor Siglec10, present on tumor-associated macrophages, providing a "don't eat me" signal that prevents targeting and phagocytosis by macrophages. Factors promoting CD24 expression could represent novel immunotherapeutic targets for ovarian cancer. Here, using a genome-wide CRISPR knockout screen, we identify GPAA1 (glycosylphosphatidylinositol anchor attachment 1), a factor that catalyzes the attachment of a glycosylphosphatidylinositol (GPI) lipid anchor to substrate proteins, as a positive regulator of CD24 cell surface expression.

View Article and Find Full Text PDF
Article Synopsis
  • Heart failure (HF) and diabetes worsen each other’s outcomes, and this study evaluated global longitudinal strain (GLS) as a prognostic marker in HF patients with diabetes.
  • In a study of 315 HF patients, those with diabetes showed significantly worse cardiovascular indicators, such as higher late gadolinium enhancement rates and elevated biomarker levels compared to non-diabetic patients.
  • The results indicated that patients with diabetes not only had poorer health indicators but also a worse prognosis, with GLS and soluble ST2 biomarkers emerging as independent prognostic factors for adverse outcomes.
View Article and Find Full Text PDF